{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:24:57Z","timestamp":1787498697672,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.avsg.2021.09.022","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T03:17:47Z","timestamp":1636427867000},"page":"316-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mid-term Efficacy and Safety of Drug-coated Balloon versus Nitinol Bare Metal Stent for Primary Lesions in Femoropopliteal Artery Disease"],"prefix":"10.1016","volume":"81","author":[{"given":"Haocheng","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingle","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2021.09.022_bib0001","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.010601","article-title":"National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis","volume":"9","author":"Song","year":"2019","journal-title":"J Glob Health"},{"key":"10.1016\/j.avsg.2021.09.022_bib0002","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1526602815592206","article-title":"An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"22","author":"Committee","year":"2015","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2021.09.022_bib0003","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.jacc.2018.09.041","article-title":"ACC\/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison","volume":"72","author":"Kithcart","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2021.09.022_bib0004","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2021.09.022_bib0005","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"European Stroke","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.avsg.2021.09.022_bib0006","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jvs.2019.01.080","article-title":"Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease","volume":"70","author":"Caradu","year":"2019","journal-title":"J of Vasc Surg"},{"key":"10.1016\/j.avsg.2021.09.022_bib0007","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jcin.2017.01.028","article-title":"2-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study","volume":"10","author":"Micari","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2021.09.022_bib0008","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jcin.2016.06.055","article-title":"Acotec Drug-Coated Balloon Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence From the AcoArt I Trial","volume":"9","author":"Jia","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2021.09.022_bib0009","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2021.09.022_bib0010","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ahj.2014.11.016","article-title":"Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial","volume":"169","author":"Jaff","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.avsg.2021.09.022_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.avsg.2021.09.022_bib0012","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamacardio.2019.0325","article-title":"Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices","volume":"4","author":"Secemsky","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.avsg.2021.09.022_bib0013","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"MC","year":"2016","journal-title":"J of Vasc Surg"},{"key":"10.1016\/j.avsg.2021.09.022_bib0014","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1526602816644592","article-title":"German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease","volume":"23","author":"Scheinert","year":"2016","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2021.09.022_bib0015","first-page":"278","article-title":"Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study","volume":"86","author":"Schroeder","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2021.09.022_bib0016","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00270-018-1940-1","article-title":"Two-Year Clinical Outcomes of the CONSEQUENT Trial: Can Femoropopliteal Lesions be Treated with Sustainable Clinical Results that are Economically Sound?","volume":"41","author":"Albrecht","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2021.09.022_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.116.004848","article-title":"Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study","volume":"10","author":"Zeller","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2021.09.022_bib0018","first-page":"311","article-title":"Mechanical rotational thrombectomy with Rotarex system augmented with drug-eluting balloon angioplasty versus stenting for the treatment of acute thrombotic and critical limb ischaemia in the femoropopliteal segment","volume":"142","author":"Pawe\u0142","year":"2019","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"key":"10.1016\/j.avsg.2021.09.022_bib0019","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.jcin.2019.08.025","article-title":"Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease","volume":"12","author":"Ouriel","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2021.09.022_bib0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1526602819852084","article-title":"IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population","volume":"26","author":"Chen","year":"2019","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2021.09.022_bib0021","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.jcin.2018.07.041","article-title":"Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions: 24-Month Results of AcoArt I","volume":"11","author":"Y","year":"2018","journal-title":"JACC. Cardiovascular interventions"},{"key":"10.1016\/j.avsg.2021.09.022_bib0022","article-title":"Impact of calcification and infrapopliteal outflow on the outcome of endovascular treatment of femoropopliteal occlusive disease","volume":"8","author":"de Athayde Soares","year":"2019","journal-title":"JRSM Cardiovasc Dis"},{"key":"10.1016\/j.avsg.2021.09.022_bib0023","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00270-018-2137-3","article-title":"Impact of Patient and Lesion Characteristics on Drug-Coated Balloon Angioplasty in the Femoropopliteal Artery: A Pooled Analysis of Four Randomized Controlled Multicenter Trials","volume":"42","author":"Albrecht","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2021.09.022_bib0024","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcin.2018.12.004","article-title":"Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The Chronic Total Occlusion Cohort in the IN.PACT Global Study","volume":"12","author":"Tepe","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2021.09.022_bib0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.avsg.2018.06.015","article-title":"Risk Factors for Restenosis after Drug-coated Balloon Angioplasty for Complex Femoropopliteal Arterial Occlusive Disease","volume":"55","author":"Roh","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.avsg.2021.09.022_bib0026","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1586\/14779072.2014.918505","article-title":"Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries","volume":"12","author":"Aghel","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.avsg.2021.09.022_bib0027","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00270-012-0492-z","article-title":"Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study","volume":"36","author":"Chalmers","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2021.09.022_bib0028","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2019.04.057","article-title":"Drug-Eluting Balloon Versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study","volume":"74","author":"Liistro","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2021.09.022_bib0029","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","article-title":"Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease","volume":"73","author":"Bausback","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2021.09.022_bib0030","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jvs.2019.02.030","article-title":"Total IN.PACT drug-coated balloon initiative reporting pooled imaging and propensity-matched cohorts","volume":"70","author":"Shishehbor","year":"2019","journal-title":"J Vasc Surg"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509621007962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509621007962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:05:48Z","timestamp":1760187948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509621007962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":30,"alternative-id":["S0890509621007962"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2021.09.022","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mid-term Efficacy and Safety of Drug-coated Balloon versus Nitinol Bare Metal Stent for Primary Lesions in Femoropopliteal Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2021.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}